Diffuse large B-cell lymphoma with concomitant c-MYC and BCL6 gene rearrangements with primary skin involvement: A case report and a review of literature
Abstract:Double-hit lymphoma (DHL) is a rare aggressive B-cell lymphoma with concomitant c-MYC, BCL2 or BCL6 gene rearrangements, which is characterized by the high frequency of extranodal lesions and by resistance to chemotherapy. The median survival does not exceed 18 months in patients with this disease. The majority of DHL is represented by с-MYC/BCL2 cases. The combination of c-MYC/BCL6 occurs rarely (5-8%). The paper describes a case of DHL with concomitant c-MYC and BCL6 gene rearrangements, which mimics diffuse… Show more
“…In a small percentage of cases these features may coexist, e.g. BCL2 and c-Myc (“double hit”), or additionally with BCL6 (“triple hit”) [ 11 ]. These subtypes are commonly associated with extranodal lesions and resistance to treatment [ 12 ].…”
“…In a small percentage of cases these features may coexist, e.g. BCL2 and c-Myc (“double hit”), or additionally with BCL6 (“triple hit”) [ 11 ]. These subtypes are commonly associated with extranodal lesions and resistance to treatment [ 12 ].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.